EPO906 in Carcinoid and Other Neuroendocrine Tumors
Clinical trial NCT00050349 · COMPLETED
Trial details
- NCT number
- NCT00050349
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-07-01
- Primary completion
- 2007-04-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.